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SUMMARY
Background
Sildenafil is an inhibitor of type 5 phosphodiesterase. It relaxes or inhibits
contraction of smooth muscle by increasing cellular concentrations of
cyclic guanosine monophosphate. Multichannel intraluminal impedance
manometry/pH allow the precise evaluation of oesophageal bolus transit
and acid/non-acid reflux.
Aim
To investigate the effect of sildenafil on segmental oesophageal motor
function and gastro-oesophageal reflux.
Methods
Eight healthy volunteers underwent multichannel intraluminal imped-
ance manometry baseline, and 15, 30 and 45 min before and after a
50-mg dose of sildenafil successively. The subjects underwent 2-h
multichannel intraluminal impedance/pH studies on two separate days
after either water or sildenafil ingestion.
Results
Sildenafil decreased the resting lower oesophageal sphincter pressure
and prolonged the duration of lower oesophageal sphincter relaxation
for the 45 min following its ingestion. At 15 min, distal onset velocity,
total bolus transit time, bolus presence time and segmental transit time
were delayed in the mid to distal oesophagus. At 30 min, distal onset
velocity was restored but bolus presence time and bolus presence time
were still delayed in distal smooth muscle segment. At 45 min, total
bolus transit time and distal onset velocity were restored but bolus pres-
ence time and segmental transit time were delayed more in the trans-
ition zone. Sildenafil did not alter the reflux.
Conclusion
Sildenafil alters lower oesophageal sphincter function and oesophageal
bolus transit, but not induce gastro-oesophageal reflux.
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INTRODUCTION
Nitric oxide (NO) is a major inhibitory neurotransmit-
ter in the enteric nervous system. It is abundantly pro-
duced in myenteric neurons that supply the terminal
motor innervation to most gastrointestinal smooth
muscles.1 It stimulates soluble guanylyl cyclase to
raise the intracellular guanosine 3¢, 5¢-cyclic mono-
phosphate (cGMP). Cyclic GMP then activates a sig-
nalling cascade that relaxes smooth muscle or inhibits
its contraction.2 The biological actions of cGMP are
terminated by phosphodiesterase (PDE) type 5. Silde-
nafil (Viagra, Pfizer Australia Pty Ltd, West Ryde, New
South Wales, Australia) antagonizes the activity of
this PDE, allowing the cellular accumulation of cGMP
and smooth muscle relaxation. Its use as a treatment
for impotence is based upon its ability to relax the
vascular smooth muscle.3
Several reports describe the effects of sildenafil on
the human oesophageal motor function. They gener-
ally agree that it decreases lower oesophageal sphinc-
ter (LES) pressure and the amplitude of peristaltic
pressure waves.4–7 These observations led to the idea
that sildenafil might be used to treat the spastic oeso-
phageal motor disorders. As yet, this has not proven
to be the case. Because it decreases LES pressure, there
is the theoretical risk of its allowing pathological gas-
tro-oesophageal reflux.
Recently, multichannel intraluminal impedance and
oesophageal manometry (MII–EM) was introduced as a
way to simultaneously evaluate the oesophageal con-
tractile activity and bolus transit.8 Combined MII and
pH recording allows the detection of reflux episodes
whether they are acid, non-acid or gas.8 We aimed to
test the hypotheses that sildenafil alters segmental
oesophageal bolus transit and increases the gastro-
oesophageal reflux.
METHODS
Subjects
Ten healthy volunteers were recruited. The exclusion
criteria were a history of hypertension, cardiovascular
disease, retinitis pigmentosa, liver failure, renal failure,
active peptic ulcer or an idiosyncratic reaction to sil-
denafil. Those who used medications that might alter
normal oesophageal motility or anti-ulcer medications
within 7 days were also excluded. Volunteers also had
no subjective oesophageal symptoms such as dyspha-
gia, globus, regurgitation or chest pain. After baseline
oesophageal manometry, two subjects were diagnosed
with nutcracker oesophagus and excluded. Two males
and six females were ultimately enrolled. The mean
age was 38.5  6.4 years and mean body mass index
was 24.9  2.1 kg/m2. An informed written consent
was obtained from each volunteer.
Study schedule
All subjects visited us three times. On the first visit, a
physical examination was performed. Particular atten-
tion was paid to the cardiovascular exam including
the blood pressure and heart rate. An electrocardio-
gram and oesophagogastroduodenoscopy were done as
baseline studies. They all underwent combined MII–
EM study before and after ingesting a 50-mg dose of
sildenafil. On the other 2 days, combined MII-pH study
was done for 2 h each day: baseline combined MII-pH
study on the second day and after a 50-mg dose of sil-
denafil on the third day.
Combined MII–EM
We used the combined MII–EM with a Koenigsberg
9-channel solid-state probe (Sandhill EFT catheter;
Sandhill Scientific Inc., Highlands Ranch, CO, USA).
The catheter has five pressure sensors: two circumfer-
ential pressure sensors located at 5 and 10 cm from
the tip and three unidirectional pressure sensors at
15, 20, and 25 cm from the tip. Impedance measuring
segments are 2 cm length and centred at 10, 15, 20,
and 25 cm from the tip, straddling the four proximal
pressure sensors. All subjects were studied in the
supine position after an overnight fast. The EFT cath-
eter was inserted trans-nasally and passed into the
stomach. It was then withdrawn slowly until LES was
identified. The catheter was positioned so that the
proximal four oesophageal pressure sensors and
impedance segments were located at 5, 10, 15, 20 cm
above the LES. The volunteers were allowed to
accommodate to the catheter for 30 min. They swal-
lowed 20 cc of water. Then, they performed three wet
swallows of 5 cc saline at 30-s intervals. Next, the
subjects were asked to swallow the sildenafil 50 mg
dissolved in 20 cc of water. We repeated the com-
bined MII–EM study in the same manner 15, 30, and
45 min after ingestion of sildenafil (Figure 1). The
subjects performed this successively without know-
ledge when they took the sildenafil.
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The resting LES pressure, residual LES pressure and
duration of LES relaxation were determined. The rest-
ing LES pressure was defined as the pressure in the
high-pressure zone measured relative to intra-gastric
pressure at the end of expiration. The parameters of
oesophageal motor function derived from oesophageal
manometry were the amplitude of peristaltic pressure
waves and distal onset velocity. The distal onset velo-
city was calculated from the time it took the peristaltic
pressure wave to travel from the most proximal to the
most distal pressure-recording site. Several parameters
of oesophageal motor function were derived from
impedance measurements. Bolus entry is defined as
the 50% point between the baseline impedance for 3 s
before a swallow and the nadir in impedance during
presence of the bolus. Bolus exit is defined as the
point on the impedance recovery curve when the
impedance rose to 50% of its preswallow baseline.
Total bolus transit time (TBTT) is the time elapsed
between bolus entry at the impedance-sensing site
20 cm above the LES and bolus exit at the impedance-
sensing site 5 cm above the LES. Bolus head advance
time is the time between bolus entry 20 cm above the
LES and bolus entry 15, 10 and 5 cm above the LES.
Bolus presence time (BPT) is the time between bolus
entry and exit at each impedance-measuring site – 5,
10, 15 and 20 cm above the LES. Segmental transit
time (STT) is the time between bolus entry at any par-
ticular level above the LES and its exit from the next
lower level. These definitions of the impedance param-
eters were introduced in the report by Tutuian et al.8
Incomplete bolus transit is defined as failure of bolus
exit at any one of the three distal impedance-measur-
ing sites.
Combined MII-pH
We used the MII-pH probe (Sandhill Scientific, Inc.). It
has four distal and two proximal impedance-measur-
ing ring electrodes and a single pH sensor at the same
level as the centre of the second distal impedance-
measuring segment. On the second visit, the MII-pH
catheter was inserted trans-nasally and positioned so
that the pH sensor was located 5 cm above the LES.
The impedance-measuring segments were located 3, 5,
7, 9, 15 and 17 cm above the LES. After insertion, the
subject swallowed 20 cc of water and then lay in the
supine position. To correlate the symptoms with reflux
events, the subject was asked to press the buttons of
the recorder (Sleuth; Sandhill Scientific Inc.) as follows;
(i) heartburn, (ii) regurgitation and (iii) acid taste. We
recorded for 2 h and determined the total number of
reflux episode, number of acid (pH < 4.0) reflux
events, non-acid episodes (pH remained above 4.0 with
a drop of no more than 1 pH U), minor acid reflux
events (pH remains above 4.0, with a drop of more
than 1 U) refluxes, and acid re-reflux (acid reflux
while pH is already <4). We also categorized the reflux
events as gas, liquid or mixed. We determined the
reflux symptom index (SI, Reflux-related symptom
events/Total symptom events *100%) and symptom
sensitivity index (SSI, Reflux-related symptom events/
Total reflux episodes *100%).9 Transient LES relaxa-
tion (TLESR) was also monitored. On the third visit,
the subject was asked to swallow sildenafil 50 mg dis-
solved in 20 cc of water and we repeated combined
MII-pH study in the same manner. We followed the
method of 2 h recording from the reports by Vela
et al.9, 10 with modification.
Figure1. Combined multichan-
nel intraluminal impedance
and oesophageal manometry
of the oesophagus before and
after 50-mg sildenafil. This is
one example of bolus transit
(top four traces in each panel)
and peristaltic pressure waves
(bottom four traces in each
panel) (a) before and (b) after
sildenafil infusion. Impedance
scale 0–3000 Ohm, pressure
scale 0–100 mmHg.
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Statistical analysis
Combined MII–EM parameters measured after the
administration of either sildenafil or placebo were
compared with baseline measurements using one-way
analysis of variance (ANOVA). Measurements evaluated
after the administration of sildenafil or placebo were
also compared using the Mann–Whitney U-test. The
Wilcoxon’s signed rank test was used to compare
the parameters of combined MII-pH study between
sildenafil and placebo. All values were expressed as
mean  S.E.M. and statistical significance was consid-
ered when P-value was <0.05.
RESULTS
Combined MII–EM Lower oesophageal sphincter
After ingesting the sildenafil, resting LES pressure
decreased by nearly 50% (Figure 2). This drop in
LES pressure was statistically different from the
baseline for the entire study (P < 0.05). Sildenafil
did not change residual LES pressure, but it length-
ened the duration of LES relaxation during the
entire experiment. Prolongation of LES relaxation
was statistically different from the baseline and pla-
cebo at all times after the ingestion of sildenafil
(P < 0.05) (Figure 3).
Oesophageal body
Sildenafil decreased the amplitude of peristaltic pres-
sure waves at 5, 10 and 15 cm above the LES (Fig-
ure 4). This decrease was statistically different from
baseline and placebo at all time points (P < 0.05). The
distal onset velocity was slowed compared with pla-
cebo only at 15 min after sildenafil ingestion
(P < 0.05) (Figure 5).
Total bolus transit time was prolonged by sildena-
fil, but the difference did not reach the statistical
significance at any time point. There was, however,
a trend towards the statistical significance at 15 and
30 min when compared with placebo (P ¼ 0.054 at
15 min, P ¼ 0.072 at 30 min) (Figure 6). Bolus pres-
ence time was lengthened at all but the most cepha-
lad-recording site 15 min after ingesting the
sildenafil (P < 0.05 at 5 cm and 15 cm, P ¼ 0.072 at
10 cm) (Figure 7). Prolongation of the BPT was also
statistically significant 10 cm above LES at 45 min
(P < 0.05 at 10 cm, P ¼ 0.054 at 15 cm). Segmental
transit time was prolonged at 15 ﬁ 10 cm and
10 ﬁ 5 cm above LES 15 min after taking the silde-
nafil (P < 0.05). While not statistically significant,
Figure 2. Effect of 50-mg sildenafil on resting lower
oesophageal sphincter (LES) pressure. Sildenafil decreased
the resting LES pressure significantly compared with that
of basal value at 15, 30, 45 min (* P < 0.05). All values
are in mean  S.E.M.
Figure 3. Effect of 50-mg sildenafil on the duration of
lower oesophageal sphincter (LES) relaxation. Sildenafil
prolonged the duration of LES relaxation during wet
swallows significantly compared with basal values at 15,
30, and 45 min (* P < 0.05), and compared with corre-
sponding placebo values at 15, 30, and 45 min
( P < 0.05). All values are in mean  S.E.M.
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STT was prolonged at 30 min in segment
10 ﬁ 5 cm (P ¼ 0.054) and at 45 min in segment
15 ﬁ 10 cm above LES (P ¼ 0.072).
Combined MII-pH
Sildenafil did not affect any of the parameters deter-
mined with combined MII-pH. Transient LES relaxa-
Figure 4. Effect of 50-mg sildenafil on the amplitude of
peristaltic pressure waves. Sildenafil significantly decreased
the amplitude of peristaltic pressure waves at 5, 10, 15 cm
above lower oesophageal sphincter compared with both the
basal value (* P < 0.05) and corresponding placebo values
( P < 0.05). All values are in mean  S.E.M.
Figure 5. Effect of 50-mg sildenafil on the distal onset
velocity of peristalsis. Sildenafil significantly prolonged
the distal onset velocity 15 min after its ingestion
compared with placebo ( P < 0.05). All values are in
mean  S.E.M.
Figure 6. Effect of 50-mg sildenafil on the total bolus
transit time (TBTT). Sildenafil delayed TBTT, but this
delay was not statistically significant. There was a trend
towards the statistical significance at 15 and 30 min after
its ingestion (P ¼ 0.054 at 15 min, P ¼ 0.072 at 30 min).
All values are in mean  S.E.M.
Figure 7. Effect of 50-mg sildenafil on the bolus presence
time (BPT). Sildenafil significantly prolonged BPT at 5,
10, 15 cm above lower oesophageal sphincter 15 min
after its ingestion, compared with basal values. It was
also delayed statistically at the 10-cm site 45 min after
its ingestion. All values are in mean  S.E.M.
(* P < 0.05).
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tion was detected only one time in one subject after
sildenafil ingestion.
DISCUSSION
In this study, we investigated the effect of the cGMP
PDE inhibitor sildenafil on oesophageal motor func-
tion and bolus movement using the combined MII–EM
equipment. We used MII-pH to determine if sildenafil
causes gastro-oesophageal reflux.
It is now well established that the NO/cGMP signal-
ling system is key to the control of oesophageal motor
function in humans and other mammalian species.
Nitric oxide produced by myenteric motor neurons
increases the cGMP concentrations in oesophageal
smooth muscle. Activation of this signalling system
controls LES relaxation and the timing of peristalsis in
the smooth muscle oesophagus. Diminishing the activ-
ity of the NO/cGMP signalling system reduces an LES
relaxation and accelerates peristalsis in the smooth
muscle oesophagus. Nitric oxide donors that activate
the cGMP signalling cascade decrease the LES tone,
but do little to oesophageal peristalsis. Zaprinast, a
type 5 (cGMP) PDE inhibitor, decreases the resting LES
tone and the amplitude of off-responses of opossum
oesophageal smooth muscle. These data suggest that
type 5 PDE inhibitors, like sildenafil, should alter
oesophageal motor function in humans.
The manometric data we obtained are similar to
what we and others described previously.4–7 Sildena-
fil diminished the resting LES pressure and pro-
longed LES relaxation. The amplitude of peristaltic
pressure waves decreased to levels defined clinically
as ineffective peristalsis. The velocity peristalsis in
the smooth muscle oesophagus was slowed, but by a
relatively small amount. Sildenafil had little effect
on peristalsis in the most proximal oesophagus. This
portion of the oesophagus is constituted by striated
muscle that is not controlled by the NO signalling
system, and is therefore not likely to be affected by
a cyclic GMP PDE inhibitor. The effect of sildenafil
on the propagation of oesophageal pressure waves
remains somewhat controversial. There are reports
that say it slows propagation and others saying it
does not. Resolution of this disparity may come
from a study by Zhang et al.11 These authors des-
cribed a slowing of peristalsis, which occurred
because the onset of peristalsis was delayed in the
smooth muscle segment of the oesophagus. This
slowing gives the appearance of a delay across the
transition zone and a fixed delay along the smooth
muscle oesophagus. Thus, observing the slowing of
propagation is likely to depend upon where in the
oesophagus it is measured.
Multichannel intraluminal impedance is a tech-
nique that tracks bolus movement in the oesopha-
gus. The impedance sensors are metallic pairs of
ring electrodes between which an alternating current
voltage is passed. When a bolus of swallowed ionic
material like saline passes a pair of electrodes,
impedance falls and current flows between the elec-
trodes increases. The measured impedance is inver-
sely proportional to current flow. As the MII/
manometry catheter has several sets of impedance
electrodes along its length, bolus movement can be
inferred from changes in impedance as the swal-
lowed material moves along the oesophagus.8, 12 In
this and our previous study, sildenafil lowered the
amplitude of peristaltic pressure waves so much that
bolus transit may be affected. The MII allowed us to
study the effects of sildenafil on liquid bolus move-
ment in the oesophagus. We observed that the char-
acteristics of bolus movement are altered by
sildenafil and that they are time-dependent. Total
bolus transit time, BPT and STT were all prolonged
in all but the most proximal oesophagus. Thus, as
oesophageal peristalsis deteriorates, the bolus dwells
longer in the smooth muscle segment of the oeso-
phagus. These changes were, in general, most pro-
nounced 15 min after taking sildenafil; the time at
which it is known to have its greatest effect.5
There is some risk that sildenafil will predispose to
gastro-oesophageal reflux because it decreases LES
pressure and the strength of peristalsis. In many clin-
ical trials, dyspepsia, a symptom often ascribed to
reflux, is one of the major side effects of sildenafil.13
In our study, dyspepsia was not observed.
Ours is the first attempt to determine whether silde-
nafil induces gastro-oesophageal reflux. Conventional
pH-metry detects only acid reflux. Combined MII-pH
is able to detect the retrograde movement (reflux) of
boluses with low impedance (i.e. liquid, food) or high
impedance (i.e. air).8 This means that MII-pH can
detect all reflux events whether acid, non-acid, minor
acid reflux, acid re-reflux, gas or mixed gas and
liquid. Vela et al. used MII-pH to evaluate the effects
of the GABA B agonist, baclofen,10 or omeprazole on
gastro-oesophageal reflux.9 They assessed the occur-
rence of postprandial acid and non-acid reflux with
2-h MII-ph studies before and after treatment. Subjects
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were given a refluxogenic meal and were placed in the
right lateral decubitus position during recording to
maximize the reflux events as they were testing the
therapeutic effects of these agents. We did not use
these refluxogenic conditions because we already
knew that sildenafil decreases LES pressure and were
interested in isolating this refluxogenic effect.
Sildenafil did not affect any of the MII-pH parame-
ters in our study. This suggests that the drop in LES
pressure we saw with sildenafil – on average to about
8 mmHg – did not predispose to gastro-oesophageal
reflux. A number of other factors are thought to pre-
dispose to gastro-oesophageal disease: immunological
responses of the oesophageal mucosa to injury,14
TLESR,15 hiatus hernia,16 and defects of acid clearing17
are all candidates. We recorded TLESR only one time
in one subject after sildenafil and none of our subjects
had a hiatus hernia.
We must say several limitations of this study.
Firstly, we selected the supine position appropriate to
study the oesophageal function, but not proper to
assess the reflux and TLESRs. In this study, decreased
LES pressure by sildenafil itself did not contribute to
GER. But this must be evaluated further under refluxo-
genic condition including the recumbent position.
Next, this is neither double blinded nor randomized
study. We recruited volunteers and determined MII–
EM and MII-pH parameters before and after the inges-
tion of sildenafil with only single-blinded manner.
But, along with the publication by Simren et al.18 in
which only severe ineffective oesophageal motility
induced by sildenafil is associated with prolonged
oesophageal clearance, at least we can conclude that
gastro-oesophageal reflux may not be a major side
effect of sildenafil.
In summary, we investigated the effect of sildenafil
on segmental oesophageal motility and gastro-oeso-
phageal reflux using combined MII–EM and MII-pH
devices. We found that sildenafil alters segmental bolus
transit and does not induce gastro-oesophageal reflux.
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